Basecare Medical Sells 35% Stake in Cellpro Biotech for USD 9.5M
Suzhou Basecare Medical Co., Ltd (HKG: 2170), a China-based IVF specialist, will sell a 35%...
Deals
Pica Partners with BrainCo to Launch ADHD Product in China
Shanghai-based primary healthcare digital platform Pica, developed by Wuxi AppTec in 2016, has partnered with...
Cosmo Pharma’s Winlevi Cream Secures Greater China Licensing Deal with 3SBio
Ireland-based Cosmo Pharmaceuticals NV (SWX: COPN) and China’s 3SBio Inc. (HKG: 1530) have signed a...
CSPC Jushi Biopharm’s SYSA1801 ADC Secures Licensing Deal with Elevation Oncology
China-based CSPC Pharmaceutical Group Ltd (HKG: 1093) announced that its subsidiary, CSPC Jushi Biopharmaceutical Co.,...
Kolo Medical Raises RMB 100M in Series B2 to Launch High-Frequency Ultrasound Imaging System
Suzhou-based Kolo Medical Inc., a leader in next-generation semiconductor ultrasound CMUT (Capacitive Micromachined Ultrasonic Transducer)...
CStone Pharmaceuticals and Kindstar Global Partner on Blood Tumor Precision Diagnosis and Treatment
China-based CStone Pharmaceuticals (HKG: 2616) announced a strategic collaboration with compatriot firm Kindstar Global (HKG:...
Wanbangde Pharmaceutical to Acquire Consun Pharma Shares in RMB 2.2B Deal
China-based Wanbangde Pharmaceutical Group has entered into a non-legally binding letter of intent with Consun...
CMS Acquires Wuhan YZY Biopharma’s Bispecific Antibody Assets for Fundus Disease
China Medical System Holdings (CMS; HKG: 0867) announced an asset transfer agreement with Wuhan YZY...
HitGen and LoQus23 Therapeutics Partner on DNA Encoded Library for Neurodegeneration
China-based HitGen Inc. (SHA: 688222) announced a strategic partnership with UK-headquartered LoQus23 Therapeutics Ltd, leveraging...
Roche Diagnostics and Topgen Biopharm Launch Innovation Center in Chongqing
Swiss diagnostics giant Roche Diagnostics and China-based Topgen Biopharm announced the establishment of a strategic...
Hybio Pharmaceutical Signs Tech Transfer Deal with China’s CDC for COVID-19 Vaccine Peptide Sequences
China-based Hybio Pharmaceutical Co., Ltd (SHE: 300199) announced that it has signed a technology transfer...
Yunnan Baiyao and Huawei Partner on AI-Driven Drug Development
Yunnan Baiyao Group Co., Ltd (SHE: 000538), a Kunming-based pharmaceutical firm, has entered into a...
Sichuan Kelun Pharmaceutical and Merck Sharp & Dohme Corp. Ink Second ADC Licensing Deal
China-based Sichuan Kelun Pharmaceutical Co., Ltd (SHE: 002422) announced that US-based Merck Sharp & Dohme...
Legend Biotech Plans USD 250M Secondary Offering to Fund CAR-T Therapy Development
China-based Legend Biotech Corporation (NASDAQ: LEGN), a specialist in chimeric antigen receptor (CAR) T cell...
Ascentage Pharma Launches Olverembatinib Named Patient Program with Tanner Pharma
China-based Ascentage Pharma (HKG: 6855) announced the launch of a Named Patient Program (NPP) for...
NMPA Approves Genuine Biotech’s Azvudine for COVID-19, Fosun Pharma Inks Licensing Deal
China’s National Medical Products Administration (NMPA) has conditionally approved HeNan Genuine Biotech Co., Ltd’s azvudine...
3D Medicines Files IPO Prospectus for Hong Kong Listing
China-based oncology specialist 3D Medicines has published its initial public offering (IPO) prospectus with the...
Rona Therapeutics Licenses Sanofi’s siRNA Platform for Global Development
Shanghai-based RNA therapeutics specialist Rona Therapeutics has entered into a licensing agreement with French pharmaceutical...
InventisBio Raises USD 308M in Shanghai STAR IPO, Valued at USD 1.54B
China-based biotech firm InventisBio (SHA: 688382) has completed an initial public offering (IPO) of 115...
MobiDrop Raises USD 14.8M in Series A+ to Expand Single-Cell Product Pipeline
China-based MobiDrop (Zhejiang) Co., Ltd has reportedly raised close to RMB 100 million (USD 14.8...